Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Anesthesiology and Surgical Oncology Research Group, Houston, Texas, USA.
Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Anesthesiology and Surgical Oncology Research Group, Houston, Texas, USA.
Best Pract Res Clin Anaesthesiol. 2019 Sep;33(3):361-371. doi: 10.1016/j.bpa.2019.07.018. Epub 2019 Jul 27.
It is expected that the number of surgical procedures to diagnose, treat, and palliate cancers will increase in the near future. While many of those interventions can be performed with minimally invasive techniques, others require surgical large incisions and in some instances, they involve multiple areas of the body (i.e., tumor resections with flap reconstructions). Pain after major oncological procedures can be severe and many times difficult to treat as patients can present to the operating room with several conditions including preoperative pain (i.e., rapidly growing tumors and painful neuropathies), opioid tolerance, and contraindications to nonopioid analgesics or regional anesthesia. Inadequately treated postoperative pain is associated with activation of the sympathetic system, postoperative complications, large perioperative opioid use, and an increased risk of developing postoperative persistent pain. Furthermore, it has been theorized that poorly treated pain is associated with cancer recurrence and a reduced survival. Lastly, recent research questions the oncological safety of robotic surgery in gynecological procedures and indicates the need of open surgeries, which will be associated with an increased risk in moderate-to-severe postoperative pain. In conclusion, the management of acute postoperative pain in patients with cancer can be challenging.
预计在不久的将来,用于诊断、治疗和缓解癌症的手术数量将会增加。虽然许多干预措施可以采用微创技术进行,但其他干预措施则需要进行大切口的外科手术,在某些情况下,还需要涉及身体的多个部位(即,带有皮瓣重建的肿瘤切除术)。重大肿瘤手术后的疼痛可能很严重,而且很多时候难以治疗,因为患者可能存在多种情况,包括术前疼痛(即,快速生长的肿瘤和疼痛性神经病变)、阿片类药物耐受和非阿片类镇痛药或区域麻醉的禁忌证。术后疼痛治疗不充分与交感神经系统的激活、术后并发症、围手术期大剂量使用阿片类药物以及发展为术后持续性疼痛的风险增加有关。此外,有理论认为,疼痛治疗不佳与癌症复发和生存率降低有关。最后,最近的研究对机器人手术在妇科手术中的肿瘤安全性提出了质疑,并表明需要进行开放性手术,这将与中重度术后疼痛的风险增加相关。总之,癌症患者急性术后疼痛的管理具有挑战性。